HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bleeding related to etonogestrel subdermal implant in a US population.

AbstractBACKGROUND:
The etonogestrel subdermal implant received US Food and Drug Administration approval in 2006. Menstrual changes represent a common reason why recipients of this implant request early implant removal.
STUDY DESIGN:
Retrospective review of medical records of 155 patients with placement of this implant at Mayo Clinic in Rochester, Minnesota, and medical literature review.
RESULTS:
In 151 patients (97.4%), this implant was placed for contraception. Sixty-four patients (41.3%) contacted a health care provider about implant-related issues after insertion, including 39 (25.2%) for abnormal bleeding. Mean body mass index (BMI) was 28.5, higher than prior studies of implant-related bleeding. Implant removal rate was 25.2% (mean interval, 9.8 months), with 14.8% requesting removal for bleeding changes. No insertion or postinsertion complications or contraceptive failures were found.
CONCLUSIONS:
Age, race, BMI, parity, prior contraception method, and postpartum and breastfeeding status did not predict bleeding or removal for bleeding risk. Removal rates were higher for amenorrhea, occasional spotting or bleeding, and regular menses than for prolonged or continuous bleeding.
AuthorsPetra M Casey, Margaret E Long, Mary L Marnach, Jessica E Bury
JournalContraception (Contraception) Vol. 83 Issue 5 Pg. 426-30 (May 2011) ISSN: 1879-0518 [Electronic] United States
PMID21477684 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Contraceptive Agents, Female
  • Drug Implants
  • etonogestrel
  • Desogestrel
Topics
  • Adolescent
  • Adult
  • Body Mass Index
  • Contraceptive Agents, Female (administration & dosage, adverse effects)
  • Desogestrel (administration & dosage, adverse effects)
  • Device Removal
  • Drug Implants (administration & dosage, adverse effects)
  • Female
  • Humans
  • Metrorrhagia (chemically induced)
  • Minnesota
  • Pregnancy
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: